reMYND's CRO announces quarterly digital Newsletter

With our quarterly Newsletter, we intend to provide our clients and contacts with some additional thoughts for the preclinical in-vivo testing of their experimental Alzheimer therapies. The one-pager will highlight particular aspects of our Services Offering, provide updates on new models and read-outs, and indicate opportunities for discussing in person at partnering events or scientific conferences.

Download the first recent edition of the quarterly Newsletter of reMYND’s CRO here, and learn about our history, the people behind the experience, and our 2011 plans to further improve our services to keep up with your research needs.

Subscribe to the quarterly Newsletter of reMYND’s CRO,  for not missing out on any edition.